Sale!

AICDA Gene Immunodeficiency Type 2 with Hyper-IgM Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AICDA Gene Immunodeficiency Type 2 with Hyper-IgM Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AICDA gene, which are responsible for a rare form of primary immunodeficiency known as Hyper-IgM Syndrome Type 2. This condition is characterized by a failure in the immune system’s ability to produce adequate levels of antibodies, except for IgM, leading to increased susceptibility to infections and other immune-related issues. The test involves analyzing the patient’s DNA to detect any genetic anomalies in the AICDA gene that may contribute to the disease.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability in results. With a cost of 4400 AED, it provides crucial information for the appropriate management and treatment of individuals affected by this condition. Early detection through this genetic test can significantly improve the quality of life for patients by facilitating targeted therapeutic interventions and monitoring strategies to prevent complications associated with Hyper-IgM Syndrome Type 2.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AICDA Gene Immunodeficiency Type 2 with hyper-IgM Genetic Test

At DNA Labs UAE, we offer the AICDA Gene Immunodeficiency Type 2 with hyper-IgM Genetic Test at a cost of AED 4400.0. This test is used to diagnose immunodeficiency type 2 with hyper-IgM and provides valuable information for patient management and genetic counseling.

Test Details

The AICDA gene is responsible for encoding the activation-induced cytidine deaminase enzyme, which is involved in the process of somatic hypermutation and class-switch recombination of immunoglobulin genes. Mutations in the AICDA gene can lead to a condition known as immunodeficiency type 2 with hyper-IgM.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. In the context of AICDA gene testing, NGS can be used to identify mutations or variants in the AICDA gene that may be associated with immunodeficiency type 2 with hyper-IgM.

NGS genetic testing involves extracting DNA from a patient’s blood or other tissue samples. The DNA is then sequenced using advanced sequencing technologies, which generate large amounts of data. Bioinformatic analysis is performed to identify any variations or mutations in the AICDA gene.

By identifying specific mutations or variants in the AICDA gene, NGS genetic testing can help diagnose immunodeficiency type 2 with hyper-IgM and provide valuable information for patient management and genetic counseling. It can also aid in understanding the underlying genetic mechanisms of the condition and potentially guide the development of targeted therapies.

Test Components

  • Price: AED 4400.0
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders

Doctor and Test Department

This test is performed by a Dermatologist and is conducted in our Genetics department.

Pre Test Information

Before undergoing the AICDA Gene Immunodeficiency Type 2 with hyper-IgM Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with AICDA Gene Immunodeficiency Type 2 with hyper-IgM NGS Genetic DNA Test gene AICDA.

Test Name AICDA Gene Immunodeficiency type 2 with hyper-IgM Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AICDA Gene Immunodeficiency type 2, with hyper-IgM NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AICDA Gene Immunodeficiency type 2, with hyper-IgM NGS Genetic DNA Test gene AICDA
Test Details

The AICDA gene is responsible for encoding the activation-induced cytidine deaminase enzyme, which is involved in the process of somatic hypermutation and class-switch recombination of immunoglobulin genes. Mutations in the AICDA gene can lead to a condition known as immunodeficiency type 2 with hyper-IgM.

NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. In the context of AICDA gene testing, NGS can be used to identify mutations or variants in the AICDA gene that may be associated with immunodeficiency type 2 with hyper-IgM.

NGS genetic testing involves extracting DNA from a patient’s blood or other tissue samples. The DNA is then sequenced using advanced sequencing technologies, which generate large amounts of data. Bioinformatic analysis is performed to identify any variations or mutations in the AICDA gene.

By identifying specific mutations or variants in the AICDA gene, NGS genetic testing can help diagnose immunodeficiency type 2 with hyper-IgM and provide valuable information for patient management and genetic counseling. It can also aid in understanding the underlying genetic mechanisms of the condition and potentially guide the development of targeted therapies.